When someone suffers an acute ischemic stroke, every moment counts. Doctors are looking for ways to stabilize patients and prevent further damage from underlying issues like intracranial atherosclerotic disease. This is a condition where plaque builds up in the blood vessels of the brain.
A new trial is being organized to test if adding a specific medication called evolocumab can help. The study will involve 416 patients who have experienced a stroke caused by these types of vessel issues. Researchers want to see if combining evolocumab with a standard dose of statin helps prevent early neurological deterioration, which is a sudden worsening of symptoms within the first three days.
Because this is currently a protocol, it means the study design has been laid out but the results are not yet available. The researchers will also track secondary goals like overall improvement in scores, changes in blood lipids, and whether patients experience a repeat stroke. While the trial plans to monitor for safety issues like bleeding, no data on outcomes exists yet.
